Standing Committee for Clinical Affairs
Recommendations
 

It is the objective of EULAR to promote task forces aimed at elaborating recommendations in the field of rheumatology. Such recommendations should strictly follow the published EULAR Standardized Operating Procedures:
 

Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, Lloyd J, Ozen S, Da Silva JA, Emery P, Kalden JR, Kvien T, Matucci-Cerinic M, Smolen J; EULAR.

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.

Ann Rheum Dis. 2004 Sep; 63(9):1172-6

 

Read more >>

 

These recommendations can be split into three different categories:

  • Recommendations for management of a specific musculoskeletal condition
  • Recommendations for conducting clinical trials in a specific musculoskeletal condition
  • Recommendations for considering the diagnosis of a specific musculoskeletal condition.
 
Recommendations for management

Recommendations for prevention and management of osteoporotic fractures

Convenor: Willem Lems 

Recommendations for determining remission in rheumatoid arthritis (joint ACR-EULAR project)

Convenor: Josef Smolen 

Recommendations for vaccination in patients with autoinflammatory rheumatic diseases

Convenor: Marc Bijl 

Recommendations for the management of rheumatoid arthritis

Convenor: Josef Smolen 

Recommendations for the prevention and treatment of osteoporosis associated with inflammatory musculoskeletal conditions

Convenor: Anthony Woolf 

Implementation of recommendations on management of systemic glucocorticoid therapy in rheumatic disease with patients

Convenor: Hans Bijlsma

Recommendations for the managment of acute swollen joint, esp. knee (in collaboration with EFORT)

Convenor: Désirée van der Heijde

Points to consider for the management of cardiovascular risk in RA

Convenor: Mike Nurmohamed

Recommendations for the management of scleroderma (EUSTAR)

Convenor: Marco Matucci-Cerinic

Read more >>

Recommendations for the management of systemic lupus erythematosus (II): Neuropsychiatric, cardiovascular, joint and skin disease and general symptoms in SLE

Convenor: Dimitrios Boumpas

Recommendations for management of ankylosing spondylitis

Convenor: Jürgen Braun

 
Recommendations for conducting clinical trials

Points to consider in the design of clinical trials in systemic sclerosis

Convenor: Daniel Furst 

Recommendations for monitoring systemic lupus erythematosus (SLE) patients in clinical practice and in observational studies

Convenor: Stefano Bombardieri 

Recommendations for conducting clinical trials with corticosteroids

Convenor: Hans Bijlsma

 

 

Recommendations for diagnosis

Recommendations for terminology, diagnosis and management of calcium pyrophosphate crystal (CPPD) associated arthritis

Convenor: Michael Doherty 

Recommendations for diagnosis of knee OA

Convenor: Michael Doherty

Points to consider for the diagnosis of systemic vasculitis (joint EULAR-ACR project)

Convenor: Richard Watts

 



RELATED INFORMATION

 

How to apply

An application (synopsis of the protocol specifying the category of recommendation [one of the 3 described in the main text], the exact title, the name of the convenor, the name of the clinical epidemiologist and the name of the experts) should be sent to the chairman of ESCCA at least 6 weeks prior to the upcoming Executive Committee meeting (in general mid-March, June at the congress and second-half of September).

 

Such application will be presented and discussed at a Executive Committee meeting, during which the decision to endorse it or not will be taken. A positive answer from the Executive Committee includes the fact that EULAR will financially support this initiative without any extra-financial support.

 

Past initiatives >>